Corium International
Feb 7, 2017
PDF

Corium to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple, Corium's President and Chief Executive Officer, will present at the BIO CEO & Investor Conference on Tuesday, February 14, 2017 at 10:30 AM EST and at the LEERINK Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 2:30 PM EST.

Audio webcasts of Corium's presentations may be accessed by visiting "Events & Presentations" in the Investors section of the Company's website at www.coriumgroup.com.  The webcasts will be archived on the Corium website for two weeks following the presentations.

About Corium

Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage the company's broad experience with advanced transdermal and transmucosal delivery systems.  Corium has multiple proprietary programs in preclinical and clinical development, focusing primarily on the treatment of neurological disorders, with lead programs in Alzheimer's disease.  Corium has developed and is the sole commercial manufacturer of seven prescription drug and consumer products with partners Mayne Pharma, Endo Pharmaceuticals and Procter & Gamble.  The company has two proprietary transdermal platforms: Corplex™ for small molecules and MicroCor®, a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides and proteins.  The company's late-stage pipeline includes a contraceptive patch co-developed with Agile Therapeutics and additional transdermal products that are being developed with other partners.  For further information, please visit www.coriumgroup.com.

Corplex™ and MicroCor® are registered trademarks of Corium International, Inc.

Source: Corium

Investor and Media Contact:

SMP Communications

Susan M. Pietropaolo

susan@smpcommunications.com

(201) 923-2049

Primary Logo

Source: Corium International, Inc.

News Provided by Acquire Media